Experimental & Translational Stroke Medicine最新文献

筛选
英文 中文
Forced arm use is superior to voluntary training for motor recovery and brain plasticity after cortical ischemia in rats. 在大鼠皮质缺血后的运动恢复和脑可塑性方面,强制手臂使用优于自主训练。
Experimental & Translational Stroke Medicine Pub Date : 2014-02-14 DOI: 10.1186/2040-7378-6-3
Armin Schneider, Andreas Rogalewski, Oliver Wafzig, Friederike Kirsch, Norbert Gretz, Carola Krüger, Kai Diederich, Claudia Pitzer, Rico Laage, Christian Plaas, Gerhard Vogt, Jens Minnerup, Wolf-Rüdiger Schäbitz
{"title":"Forced arm use is superior to voluntary training for motor recovery and brain plasticity after cortical ischemia in rats.","authors":"Armin Schneider,&nbsp;Andreas Rogalewski,&nbsp;Oliver Wafzig,&nbsp;Friederike Kirsch,&nbsp;Norbert Gretz,&nbsp;Carola Krüger,&nbsp;Kai Diederich,&nbsp;Claudia Pitzer,&nbsp;Rico Laage,&nbsp;Christian Plaas,&nbsp;Gerhard Vogt,&nbsp;Jens Minnerup,&nbsp;Wolf-Rüdiger Schäbitz","doi":"10.1186/2040-7378-6-3","DOIUrl":"https://doi.org/10.1186/2040-7378-6-3","url":null,"abstract":"<p><strong>Background and purpose: </strong>Both the immobilization of the unaffected arm combined with physical therapy (forced arm use, FAU) and voluntary exercise (VE) as model for enriched environment are promising approaches to enhance recovery after stroke. The genomic mechanisms involved in long-term plasticity changes after different means of rehabilitative training post-stroke are largely unexplored. The present investigation explored the effects of these physical therapies on behavioral recovery and molecular markers of regeneration after experimental ischemia.</p><p><strong>Methods: </strong>42 Wistar rats were randomly treated with either forced arm use (FAU, 1-sleeve plaster cast onto unaffected limb at 8/10 days), voluntary exercise (VE, connection of a freely accessible running wheel to cage), or controls with no access to a running wheel for 10 days starting at 48 hours after photothrombotic stroke of the sensorimotor cortex. Functional outcome was measured using sensorimotor test before ischemia, after ischemia, after the training period of 10 days, at 3 and 4 weeks after ischemia. Global gene expression changes were assessed from the ipsi- and contralateral cortex and the hippocampus.</p><p><strong>Results: </strong>FAU-treated animals demonstrated significantly improved functional recovery compared to the VE-treated group. Both were superior to cage control. A large number of genes are altered by both training paradigms in the ipsi- and contralateral cortex and the hippocampus. Overall, the extent of changes observed correlated well with the functional recovery obtained. One category of genes overrepresented in the gene set is linked to neuronal plasticity processes, containing marker genes such as the NMDA 2a receptor, PKC ζ, NTRK2, or MAP 1b.</p><p><strong>Conclusions: </strong>We show that physical training after photothrombotic stroke significantly and permanently improves functional recovery after stroke, and that forced arm training is clearly superior to voluntary running training. The behavioral outcomes seen correlate with patterns and extent of gene expression changes in all brain areas examined. We propose that physical training induces a fundamental change in plasticity-relevant gene expression in several brain regions that enables recovery processes. These results contribute to the debate on optimal rehabilitation strategies, and provide a valuable source of molecular entry points for future pharmacological enhancement of recovery.</p>","PeriodicalId":12158,"journal":{"name":"Experimental & Translational Stroke Medicine","volume":"6 1","pages":"3"},"PeriodicalIF":0.0,"publicationDate":"2014-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/2040-7378-6-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32117216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Analysis of early phase and subsequent phase III stroke studies of neuroprotectants: outcomes and predictors for success. 神经保护剂的早期和随后的III期中风研究分析:结果和成功的预测因素。
Experimental & Translational Stroke Medicine Pub Date : 2014-02-07 DOI: 10.1186/2040-7378-6-2
Jens Minnerup, Heike Wersching, Matthias Schilling, Wolf Rüdiger Schäbitz
{"title":"Analysis of early phase and subsequent phase III stroke studies of neuroprotectants: outcomes and predictors for success.","authors":"Jens Minnerup,&nbsp;Heike Wersching,&nbsp;Matthias Schilling,&nbsp;Wolf Rüdiger Schäbitz","doi":"10.1186/2040-7378-6-2","DOIUrl":"https://doi.org/10.1186/2040-7378-6-2","url":null,"abstract":"<p><strong>Background: </strong>Efficacy of neuroprotective treatments for ischemic stroke was not convincingly demonstrated in clinical phase III trials so far, whereas some preceding early phase studies found neuroprotection to be beneficial. We aimed to determine the frequency with which phase III studies are preceded by positive early phase studies, and to identify characteristics of early phase studies that are associated with correct prediction of phase III studies.</p><p><strong>Methods: </strong>We identified phase III studies and corresponding early phase studies of neuroprotective treatments for stroke. Data on study characteristics of early phase trials were extracted and compared between studies that were classified according to their results as \"false positive\" and \"true neutral\" using logistic regression analysis.</p><p><strong>Results: </strong>Forty-six phase III studies and 59 corresponding early phase studies were identified. Only one phase III study was positive and this study was followed by a larger negative study. Twenty-two (37.3%) early phase studies were considered to be false positive and 37 (62.7%) to be true neutral. None of the early phase study characteristics were significantly associated with correct prediction of phase III studies.</p><p><strong>Conclusions: </strong>More than one third of early phase studies on neuroprotective stroke treatments are false positive. Neither the results nor specific study design characteristics of early phase stroke studies reliably predict success in phase III trials. Further efforts are needed to improve early phase studies regarding its predictability and to identify those early studies that should be advanced to phase III trials.</p>","PeriodicalId":12158,"journal":{"name":"Experimental & Translational Stroke Medicine","volume":"6 1","pages":"2"},"PeriodicalIF":0.0,"publicationDate":"2014-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/2040-7378-6-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32094804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 30
Intravital imaging in spontaneously hypertensive stroke-prone rats-a pilot study. 自发性高血压卒中易发大鼠的活体影像研究。
Experimental & Translational Stroke Medicine Pub Date : 2014-01-25 DOI: 10.1186/2040-7378-6-1
Solveig Niklass, Stoyan Stoyanov, Cornelia Garz, Celine Z Bueche, Stine Mencl, Klaus Reymann, Hans-Jochen Heinze, Roxana O Carare, Christoph Kleinschnitz, Stefanie Schreiber
{"title":"Intravital imaging in spontaneously hypertensive stroke-prone rats-a pilot study.","authors":"Solveig Niklass,&nbsp;Stoyan Stoyanov,&nbsp;Cornelia Garz,&nbsp;Celine Z Bueche,&nbsp;Stine Mencl,&nbsp;Klaus Reymann,&nbsp;Hans-Jochen Heinze,&nbsp;Roxana O Carare,&nbsp;Christoph Kleinschnitz,&nbsp;Stefanie Schreiber","doi":"10.1186/2040-7378-6-1","DOIUrl":"https://doi.org/10.1186/2040-7378-6-1","url":null,"abstract":"<p><strong>Background: </strong>There is growing evidence that endothelial failure and subsequent blood brain barrier (BBB) breakdown initiate cerebral small vessel disease (CSVD) pathology. In spontaneously hypertensive stroke-prone rats (SHRSP) endothelial damage is indicated by intraluminal accumulations of erythrocytes (erythrocyte thrombi) that are not observed with current magnetic resonance imaging techniques. Two-photon microscopy (2 PM) offers the potential for real-time direct detection of the small vasculature. Thus, within this pilot study we investigated the sensitivity of 2 PM to detect erythrocyte thrombi expressing initiating CSVD phenomena in vivo.</p><p><strong>Methods: </strong>Eight SHRSP and 13 Wistar controls were used for in vivo imaging and subsequent histology with haematoxylin-eosin (HE). For 2 PM, cerebral blood vessels were labeled by fluorescent Dextran (70 kDa) applied intraorbitally. The correlation between vascular erythrocyte thrombi observed by 2 PM and HE-staining was assessed. Artificial surgical damage and parenchymal Dextran distribution were analyzed postmortem.</p><p><strong>Results: </strong>Dextran was distributed within the small vessel walls and co-localized with IgG.Artificial surgical damage was comparable between SHRSP and Wistar controls and mainly affected the small vasculature. In fewer than 20% of animals there was correlation between erythrocyte thrombi as observed with 2 PM and histologically with HE.</p><p><strong>Conclusions: </strong>Contrary to our initial expectations, there was little agreement between intravital 2 PM imaging and histology for the detection of erythrocyte thrombi. Two-photon microscopy is a valuable technique that complements but does not replace the value of conventional histology.</p>","PeriodicalId":12158,"journal":{"name":"Experimental & Translational Stroke Medicine","volume":"6 1","pages":"1"},"PeriodicalIF":0.0,"publicationDate":"2014-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/2040-7378-6-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32061270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Ischemia-induced cell depolarization: does the hyperpolarization-activated cation channel HCN2 affect the outcome after stroke in mice? 缺血诱导的细胞去极化:超极化激活的阳离子通道HCN2是否影响小鼠脑卒中后的预后?
Experimental & Translational Stroke Medicine Pub Date : 2013-12-27 DOI: 10.1186/2040-7378-5-16
Petra Ehling, Eva Göb, Stefan Bittner, Thomas Budde, Andreas Ludwig, Christoph Kleinschnitz, Sven G Meuth
{"title":"Ischemia-induced cell depolarization: does the hyperpolarization-activated cation channel HCN2 affect the outcome after stroke in mice?","authors":"Petra Ehling,&nbsp;Eva Göb,&nbsp;Stefan Bittner,&nbsp;Thomas Budde,&nbsp;Andreas Ludwig,&nbsp;Christoph Kleinschnitz,&nbsp;Sven G Meuth","doi":"10.1186/2040-7378-5-16","DOIUrl":"https://doi.org/10.1186/2040-7378-5-16","url":null,"abstract":"<p><strong>Background: </strong>Brain ischemia is known to include neuronal cell death and persisting neurological deficits. A lack of oxygen and glucose are considered to be key mediators of ischemic neurodegeneration while the exact mechanisms are yet unclear. In former studies the expression of two different two-pore domain potassium (K2P) channels (TASK1, TREK1) were shown to ameliorate neuronal damage due to cerebral ischemia. In neurons, TASK channels carrying hyperpolarizing K+ leak currents, and the pacemaker channel HCN2, carrying depolarizing Ih, stabilize the membrane potential by a mutual functional interaction. It is assumed that this ionic interplay between TASK and HCN2 channels enhances the resistance of neurons to insults accompanied by extracellular pH shifts.</p><p><strong>Methods: </strong>In C57Bl/6 (wildtype, WT), hcn2+/+ and hcn2-/- mice we used an in vivo model of cerebral ischemia (transient middle cerebral artery occlusion (tMCAO)) to depict a functional impact of HCN2 in stroke formation. Subsequent analyses comprise behavioural tests and hcn2 gene expression assays.</p><p><strong>Results: </strong>After 60 min of tMCAO induction in WT mice, we collected tissue samples at 6, 12, and 24 h after reperfusion. In the infarcted neocortex, hcn2 expression analyses revealed a nominal peak of hcn2 expression 6 h after reperfusion with a tendency towards lower expression levels with longer reperfusion times. Hcn2 gene expression levels in infarcted basal ganglia did not change after 6 h and 12 h. Only at 24 h after reperfusion, hcn2 expression significantly decreases by ~55%. However, 30 min of tMCAO in hcn2-/- as well as hcn2+/+ littermates induced similar infarct volumes. Behavioural tests for global neurological function (Bederson score) and motor function/coordination (grip test) were performed at day 1 after surgery. Again, we found no differences between the groups.</p><p><strong>Conclusions: </strong>Here, we hypothesized that the absence of HCN2, an important functional counter player of TASK channels, affects neuronal survival during stroke-induced tissue damage. However, together with a former study on TASK3 these results implicate that both TASK3 and HCN2 which were supposed to be neuroprotective due to their pH-dependency, do not influence ischemic neurodegeneration during stroke in the tMCAO model.</p>","PeriodicalId":12158,"journal":{"name":"Experimental & Translational Stroke Medicine","volume":"5 1","pages":"16"},"PeriodicalIF":0.0,"publicationDate":"2013-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/2040-7378-5-16","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31984654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Report on the 5'th scientific meeting of the "Verein zur Förderung des Wissenschaftlichen Nachwuchses in der Neurologie" (NEUROWIND e.V.) held in Motzen, Germany, Oct. 25th - Oct. 27th, 2013. 他们说作为先锋的我被开除了
Experimental & Translational Stroke Medicine Pub Date : 2013-12-11 DOI: 10.1186/2040-7378-5-15
Ralf A Linker, Tim Magnus, Thomas Korn, Christoph Kleinschnitz, Sven G Meuth
{"title":"Report on the 5'th scientific meeting of the \"Verein zur Förderung des Wissenschaftlichen Nachwuchses in der Neurologie\" (NEUROWIND e.V.) held in Motzen, Germany, Oct. 25th - Oct. 27th, 2013.","authors":"Ralf A Linker,&nbsp;Tim Magnus,&nbsp;Thomas Korn,&nbsp;Christoph Kleinschnitz,&nbsp;Sven G Meuth","doi":"10.1186/2040-7378-5-15","DOIUrl":"https://doi.org/10.1186/2040-7378-5-15","url":null,"abstract":"<p><p>From october 25th - 27th 2013, the 5th NEUROWIND e.V. meeting was held in Motzen, Brandenburg, Germany. This year more than 60 doctoral students and postdocs from over 25 different groups working in German university hospitals or research institutes attended the meeting to discuss their latest findings in the fields of neuroimmunology, neurodegeneration and neurovascular research. All participants appreciated the stimulating environment in Motzen, Brandenburg, and people took the opportunity for scientific exchange, discussion about ongoing projects and already started further collaborations. Like in the previous years, the symposium was regarded as a very well organized platform to support research of young investigators in Germany.According to the major aim of NEUROWIND e.V. to support younger researchers in Germany the 3rd NEUROWIND YOUNG SCIENTIST AWARD for experimental neurology was awarded to Ruth Stassart working in the group of Klaus Armin Nave and Wolfgang Brück (MPI Göttingen and Department of Neuropathology, Göttingen Germany). The successful work was published in Nature Neuroscience entitled \"A role for Swann cell-derived neuregulin-1 in remyelination\". This outstanding paper deals with the function of Schwann cell neuregulin as an endogenous factor for myelin repair. The award is endowed with 20.000 Euro sponsored by Merck Serono GmbH, Darmstadt, Germany (unrestricted educational grant).This year's keynote lecture was given by Albert Ludolph, Head of the Department of Neurology at the University Clinic of Ulm. Dr. Ludolph highlighted the particular role of individual scientists for the development of research concepts in Alzheimer´s disease (AD) and frontotemporal dementia (FTD). </p>","PeriodicalId":12158,"journal":{"name":"Experimental & Translational Stroke Medicine","volume":"5 1","pages":"15"},"PeriodicalIF":0.0,"publicationDate":"2013-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/2040-7378-5-15","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31948705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Guideline clinical nutrition in patients with stroke. 脑卒中患者临床营养指南。
Experimental & Translational Stroke Medicine Pub Date : 2013-12-01 DOI: 10.1186/2040-7378-5-14
Rainer Wirth, Christine Smoliner, Martin Jäger, Tobias Warnecke, Andreas H Leischker, Rainer Dziewas
{"title":"Guideline clinical nutrition in patients with stroke.","authors":"Rainer Wirth,&nbsp;Christine Smoliner,&nbsp;Martin Jäger,&nbsp;Tobias Warnecke,&nbsp;Andreas H Leischker,&nbsp;Rainer Dziewas","doi":"10.1186/2040-7378-5-14","DOIUrl":"https://doi.org/10.1186/2040-7378-5-14","url":null,"abstract":"<p><p>Stroke is regularly accompanied by dysphagia and other factors associated with decreased nutritional intake. Dysphagia with aspiration pneumonia and insufficient nutritional intake lead to worse outcome after stroke.This guideline is the first chapter of the guideline \"Clinical Nutrition in Neurology\" of the German Society for Clinical Nutrition (DGEM) which itself is one part of a comprehensive guideline about all areas of Clinical Nutrition. The thirty-one recommendations of the guideline are based on a systematic literature search and review, last updated December 31, 2011. All recommendations were discussed and consented at several consensus conferences with the entire DGEM guideline group. The recommendations underline the importance of an early screening and assessment of dysphagia and give advice for an evidence based and comprehensive nutritional management to avoid aspiration, malnutrition and dehydration. </p>","PeriodicalId":12158,"journal":{"name":"Experimental & Translational Stroke Medicine","volume":"5 1","pages":"14"},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/2040-7378-5-14","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31913811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 122
Age-dependence of sensorimotor and cerebral electroencephalographic asymmetry in rats subjected to unilateral cerebrovascular stroke. 单侧脑血管中风大鼠感觉运动和脑电图不对称的年龄依赖性。
Experimental & Translational Stroke Medicine Pub Date : 2013-11-19 DOI: 10.1186/2040-7378-5-13
Slavianka G Moyanova, Rumiana G Mitreva, Lidia V Kortenska, Ferdinando Nicoletti, Richard T Ngomba
{"title":"Age-dependence of sensorimotor and cerebral electroencephalographic asymmetry in rats subjected to unilateral cerebrovascular stroke.","authors":"Slavianka G Moyanova,&nbsp;Rumiana G Mitreva,&nbsp;Lidia V Kortenska,&nbsp;Ferdinando Nicoletti,&nbsp;Richard T Ngomba","doi":"10.1186/2040-7378-5-13","DOIUrl":"https://doi.org/10.1186/2040-7378-5-13","url":null,"abstract":"<p><strong>Background: </strong>The human population mostly affected by stroke is more than 65 years old. This study was designed to meet the recommendation that models of cerebral ischemia in aged animals are more relevant to the clinical setting than young animal models. Until now the majority of the pre-clinical studies examining age effects on stroke outcomes have used rats of old age. Considering the increasing incidence of stroke among younger than old human population, new translational approaches in animal models are needed to match the rejuvenation of stroke. A better knowledge of alterations in stroke outcomes in middle-aged rats has important preventive and management implications providing clues for future investigations on effects of various neuroprotective and neurorestorative drugs against cerebrovascular accidents that may occur before late senescence.</p><p><strong>Methods: </strong>We evaluated the impact of transient focal ischemia, induced by intracerebral unilateral infusion of endothelin-1 (Et-1) near the middle cerebral artery of conscious rats, on volume of brain damage and asymmetry in behavioral and electroencephalographic (EEG) output measures in middle-aged (11-12 month-old) rats.</p><p><strong>Results: </strong>We did not find any age-dependent difference in the volume of ischemic brain damage three days after Et-1 infusion. However, age was an important determinant of neurological and EEG outcomes after stroke. Middle-aged ischemic rats had more impaired somatosensory functions of the contralateral part of the body than young ischemic rats and thus, had greater left-right reflex/sensorimotor asymmetry. Interhemispheric EEG asymmetry was more evident in middle-aged than in young ischemic rats, and this could tentatively explain the behavioral asymmetry.</p><p><strong>Conclusions: </strong>With a multiparametric approach, we have validated the endothelin model of ischemia in middle-aged rats. The results provide clues for future studies on mechanisms underlying plasticity after brain damage and motivate investigations of novel neuroprotective strategies against cerebrovascular accidents that may occur before late senescence.</p>","PeriodicalId":12158,"journal":{"name":"Experimental & Translational Stroke Medicine","volume":"5 1","pages":"13"},"PeriodicalIF":0.0,"publicationDate":"2013-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/2040-7378-5-13","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31875145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Anti-inflammatory IL-10 is upregulated in both hemispheres after experimental ischemic stroke: Hypertension blunts the response. 实验性缺血性脑卒中后,抗炎IL-10在两脑半球上调:高血压使反应减弱。
Experimental & Translational Stroke Medicine Pub Date : 2013-11-13 DOI: 10.1186/2040-7378-5-12
Abdelrahman Y Fouda, Anna Kozak, Ahmed Alhusban, Jeffrey A Switzer, Susan C Fagan
{"title":"Anti-inflammatory IL-10 is upregulated in both hemispheres after experimental ischemic stroke: Hypertension blunts the response.","authors":"Abdelrahman Y Fouda,&nbsp;Anna Kozak,&nbsp;Ahmed Alhusban,&nbsp;Jeffrey A Switzer,&nbsp;Susan C Fagan","doi":"10.1186/2040-7378-5-12","DOIUrl":"https://doi.org/10.1186/2040-7378-5-12","url":null,"abstract":"<p><strong>Background: </strong>Exogenous administration of the anti-inflammatory cytokine, interleukin 10 (IL-10), is known to promote neuroprotection and mitigate neuroinflammation after ischemia. However, endogenous expression and localization of IL-10 and its receptor (IL-10R) in the post-ischemic brain are still to be elucidated. In this investigation we aimed at determining the temporospatial expression of IL-10 in the rat brain relative to its systemic levels after ischemic stroke.</p><p><strong>Methods: </strong>Wistar rats were subjected to either permanent (pMCAO) or 3-h temporary (tMCAO) middle cerebral artery occlusion and euthanized at either 24 or 72 h. IL-10/IL-10R levels were quantified in ischemic and contralesional hemispheres and compared to shams using multiplex bead array and Western blotting, respectively. Localization of IL-10/IL-10R with markers for neurons, microglia, astrocytes & endothelial cells were examined using double labeling immunofluorescence. IL-10 was also quantified in the brain tissue of spontaneously hypertensive rats (SHRs) at 24 h after tMCAO.</p><p><strong>Results: </strong>After both pMCAO and tMCAO in Wistars, IL-10 was significantly upregulated in both hemispheres by ≈ 50% at 24 h while IL-10R expression was significantly decreased only at 72 h in the ischemic hemisphere. IL-10 and IL-10R expression highly co-localized with viable neurons in the ischemic penumbra and contralesional hemisphere. In hypertensive rats, IL-10 showed no significant contralesional upregulation and declined significantly in the ischemic side at 24 h post-ischemia.</p><p><strong>Conclusion: </strong>Our data highlights the involvement of the ischemic and contralesional neurons in the endogenous anti-inflammatory response after ischemic stroke through increased production of IL-10. This increase in IL-10 is blunted in hypertensive animals and may contribute to worse outcomes.</p>","PeriodicalId":12158,"journal":{"name":"Experimental & Translational Stroke Medicine","volume":"5 1","pages":"12"},"PeriodicalIF":0.0,"publicationDate":"2013-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/2040-7378-5-12","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32094094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 37
Coadministration of FTY720 and rt-PA in an experimental model of large hemispheric stroke-no influence on functional outcome and blood-brain barrier disruption. FTY720和rt-PA在大半球脑卒中实验模型中的联合应用-对功能结局和血脑屏障破坏无影响。
Experimental & Translational Stroke Medicine Pub Date : 2013-10-28 DOI: 10.1186/2040-7378-5-11
Aijia Cai, Frieder Schlunk, Ferdinand Bohmann, Sepide Kashefiolasl, Robert Brunkhorst, Christian Foerch, Waltraud Pfeilschifter
{"title":"Coadministration of FTY720 and rt-PA in an experimental model of large hemispheric stroke-no influence on functional outcome and blood-brain barrier disruption.","authors":"Aijia Cai,&nbsp;Frieder Schlunk,&nbsp;Ferdinand Bohmann,&nbsp;Sepide Kashefiolasl,&nbsp;Robert Brunkhorst,&nbsp;Christian Foerch,&nbsp;Waltraud Pfeilschifter","doi":"10.1186/2040-7378-5-11","DOIUrl":"https://doi.org/10.1186/2040-7378-5-11","url":null,"abstract":"<p><strong>Background: </strong>Systemic thrombolysis with recombinant tissue plasminogen activator (rt-PA) is the standard of acute stroke care. Its potential to increase the risk of secondary intracerebral hemorrhage, especially if administered late, has been ascribed to its proteolytic activity that has detrimental effects on blood-brain barrier (BBB) integrity after stroke. FTY720 has been shown to protect endothelial barriers in several disease models such as endotoxin-induced pulmonary edema and therefore is a promising candidate to counteract the deleterious effects of rt-PA. Besides that, every putative neuroprotectant that will be eventually forwarded into clinical trials should be tested in conjunction with rt-PA.</p><p><strong>Methods: </strong>We subjected C57Bl/6 mice to 3 h filament-induced tMCAO and postoperatively randomized them into four groups (n = 18/group) who received the following treatments directly prior to reperfusion: 1) vehicle-treatment, 2) FTY720 1 mg/kg i.p., 3) rt-PA 10 mg/kg i.v. or 4) FTY720 and rt-PA as a combination therapy. We measured functional neurological outcome, BBB disruption by quantification of EB extravasation and MMP-9 activity by gelatin zymography.</p><p><strong>Results: </strong>We observed a noticeable increase in mortality in the rt-PA/FTY720 cotreatment group (61%) as compared to the vehicle (33%), the FTY720 (39%) and the rt-PA group (44%). Overall, functional neurological outcome did not differ significantly between groups and FTY720 had no effect on rt-PA- and stroke-induced BBB disruption and MMP-9 activation.</p><p><strong>Conclusions: </strong>Our data show that FTY720 does not improve functional outcome and BBB integrity in large hemispheric infarctions, neither alone nor in conjunction with rt-PA. These findings stand in contrast to a recently published study that showed beneficial effects of FTY720 in combination with thrombolysis in a thrombotic model of MCAO leading to circumscript cortical infarctions. They might therefore represent a caveat that the coadministration of these two drugs might lead to excess mortality in the setting of a severe stroke.</p>","PeriodicalId":12158,"journal":{"name":"Experimental & Translational Stroke Medicine","volume":"5 1","pages":"11"},"PeriodicalIF":0.0,"publicationDate":"2013-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/2040-7378-5-11","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"32094621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Correction: Reduced infarct size in neuroglobin-null mice after experimental stroke in vivo. 校正:体内实验脑卒中后神经球蛋白缺失小鼠梗死面积减小。
Experimental & Translational Stroke Medicine Pub Date : 2013-08-08 DOI: 10.1186/2040-7378-5-10
Zindy Raida, Christian Ansgar Hundahl, Jesper Kelsen, Jens Randel Nyengaard, Anders Hay-Schmidt
{"title":"Correction: Reduced infarct size in neuroglobin-null mice after experimental stroke in vivo.","authors":"Zindy Raida,&nbsp;Christian Ansgar Hundahl,&nbsp;Jesper Kelsen,&nbsp;Jens Randel Nyengaard,&nbsp;Anders Hay-Schmidt","doi":"10.1186/2040-7378-5-10","DOIUrl":"https://doi.org/10.1186/2040-7378-5-10","url":null,"abstract":"","PeriodicalId":12158,"journal":{"name":"Experimental & Translational Stroke Medicine","volume":"5 1","pages":"10"},"PeriodicalIF":0.0,"publicationDate":"2013-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/2040-7378-5-10","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31641391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信